Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Migration of cytotoxic effector cells

A V LeFever¹, R L Truitt

¹Department of Pediatrics, Medical College of Wisconsin, Children's Hospital, Milwaukee 53233.

Progress in Clinical and Biological Research

|January 1, 1987

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis.

Cytotherapy·2007

Same author

Donor natural killer (NK1.1+) cells do not play a role in the suppression of GVHD or in the mediation of GVL reactions after DLI.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2002

Same author

Immune modulation in cancer patients after adoptive transfer of anti-CD3/anti-CD28-costimulated T cells-phase I clinical trial.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2001

Same author

T cells activated in vitro as immunotherapy for renal cell carcinoma: characterization of 2 effector T-cell populations.

The Journal of urology·2001

Same author

Use of anti-CD3 x anti-HER2/neu bispecific antibody for redirecting cytotoxicity of activated T cells toward HER2/neu+ tumors.

Journal of hematotherapy & stem cell research·2001

Same author

Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.

Journal of immunology (Baltimore, Md. : 1950)·1999